Evaluation of Cell Line Identity Using RTCA Profiling for Quality Control of Products Containing Viable Human Cells

Author:

Vodyakova M. A.1ORCID,Rachinskaya O. A.1ORCID,Pokrovsky N. S.1ORCID,Semenova I. S.1ORCID,Melnikova E. V.1ORCID,Merkulov V. A.1ORCID

Affiliation:

1. Scientific Centre for Expert Evaluation of Medicinal Products

Abstract

Introduction. Identity is an important quality attribute of products containing viable human cells, to be tested during the quality control. The verification of identity includes, among other things, determination of the proliferative activity of the cell lines included in such products. The Agilent xCELLigence real-time cell analysis (RTCA) DP (dual purpose) instrument (USA) for continuous, label-free in vitro analysis can be used to assess the cell proliferative activity.Aim. Demonstration of reproducibility of the RTCA profiling technique as a test method for primary verification of the cell line identity.Materials and methods. An xCELLigence RTCA DP cell analyzer (Agilent Technologies, USA) was used to obtain RTCA profiles of dermal fibroblast (DF-2) and adipose tissue-derived mesenchymal stromal (MSC AT_D122) cell lines. The experiment was carried out in triplicate after thawing three different vials from the same batch for each cell line.Results and discussion. The RTCA profiles were obtained for DF-2 and MSC AT_D122 cell lines. The statistical processing of the results was carried out using the Friedman test, confidence intervals, and growth curve parameters obtained by the instrument (doubling time, proliferation rate, and maximum cell index). The obtained data demonstrate no differences in the RTCA profiles after parallel sampling of the contents from three vials for each cell line.Conclusion. The RTCA profiling reproducibility was confirmed in order to assess the cell analyzer’s applicability to cell line identity.

Publisher

Center of Pharmaceutical Analytics Ltd

Subject

Drug Discovery,Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3